Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Trading 0.3% Higher - Time to Buy?

Key Points

• Bayer Aktiengesellschaft's shares rose by 0.3%, trading at $7.93 with a significant drop in volume, down 12% from average session levels.
• Analyst ratings for Bayer have been mixed, with upgrades to "strong-buy" from Goldman Sachs and HSBC, but a downgrade to "hold" from Zacks Research.
• The company reported quarter earnings exceeding expectations, with $0.35 EPS on $12.42 billion in revenue, surpassing analyst forecasts of $0.25 EPS on $10.79 billion in revenue.

Shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) traded up 0.3% during trading on Friday . The company traded as high as $7.96 and last traded at $7.93. 310,869 shares traded hands during mid-day trading, a decline of 12% from the average session volume of 353,724 shares. The stock had previously closed at $7.91.

Analyst Ratings Changes

A number of analysts have commented on the stock. The Goldman Sachs Group upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Zacks Research downgraded shares of Bayer Aktiengesellschaft from a "strong-buy" rating to a "hold" rating in a report on Monday, September 1st. Hsbc Global Res upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Wednesday, June 11th. Kepler Capital Markets upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. Finally, Wall Street Zen upgraded shares of Bayer Aktiengesellschaft from a "buy" rating to a "strong-buy" rating in a report on Tuesday, August 19th. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy".

Bayer Aktiengesellschaft Price Performance

The company has a current ratio of 1.13, a quick ratio of 0.73 and a debt-to-equity ratio of 1.04. The firm has a market cap of $31.16 billion, a price-to-earnings ratio of -8.18, a P/E/G ratio of 3.61 and a beta of 0.93. The stock's fifty day moving average price is $8.05 and its 200-day moving average price is $7.27.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.10. The firm had revenue of $12.42 billion during the quarter, compared to analysts' expectations of $10.79 billion. Bayer Aktiengesellschaft had a negative net margin of 7.61% and a positive return on equity of 15.44%. As a group, equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.